TLDRs; Tesla cut the price of its long-range Model 3 in China by nearly 4%, starting at 259,500 yuan. The company is offering incentives, including insurance subsidies and five-year interest-free loans, to boost sales. Tesla’s market share in China has plunged from 16% in 2020 to just 3.2% this year. Domestic rivals like BYD, Geely, [...] The post Tesla Cuts Model 3 Price in China Amid Intensifying EV Price War appeared first on CoinCentral.TLDRs; Tesla cut the price of its long-range Model 3 in China by nearly 4%, starting at 259,500 yuan. The company is offering incentives, including insurance subsidies and five-year interest-free loans, to boost sales. Tesla’s market share in China has plunged from 16% in 2020 to just 3.2% this year. Domestic rivals like BYD, Geely, [...] The post Tesla Cuts Model 3 Price in China Amid Intensifying EV Price War appeared first on CoinCentral.

Tesla Cuts Model 3 Price in China Amid Intensifying EV Price War

TLDRs;

  • Tesla cut the price of its long-range Model 3 in China by nearly 4%, starting at 259,500 yuan.
  • The company is offering incentives, including insurance subsidies and five-year interest-free loans, to boost sales.
  • Tesla’s market share in China has plunged from 16% in 2020 to just 3.2% this year.
  • Domestic rivals like BYD, Geely, XPeng, and Xiaomi are outpacing Tesla with cheaper prices and rapid delivery growth.

Tesla has announced a price reduction for its latest long-range Model 3 sedan in China, just days before customer deliveries are scheduled to begin.

The electric vehicle (EV), manufactured in Shanghai and boasting an impressive 830-kilometer driving range, will now retail starting at 259,500 yuan (US$36,400). This represents a nearly 4% cut, or about 10,000 yuan (US$1,402), from the previously announced price.

The timing of the cut highlights the urgency Tesla faces as competition in the world’s largest EV market heats up. Alongside the price reduction, Tesla is sweetening the deal for Chinese buyers with additional perks. Customers can now access an 8,000 yuan (US$1,122) insurance subsidy and a five-year, interest-free loan option, which could save buyers up to 20,000 yuan overall.

Competition Puts Pressure on Tesla Margins

Tesla’s decision is seen as a response to a fierce price war that has gripped China’s EV market. Over the past two years, average car prices in China have fallen by 19%, with electric cars now selling for less than gasoline-powered vehicles, an unprecedented reversal compared to five years ago.

Industry leader BYD, which has outpaced Tesla in sales volume, reported a 30% decline in second-quarter profits despite growing delivery numbers. The company attributed the drop directly to intensified price competition. Other domestic players, such as Geely and XPeng, have also been aggressively cutting prices while expanding market share.

Tesla’s modest 4% reduction, when compared to the steeper cuts made by local rivals, underscores the company’s challenge of maintaining its premium image while staying competitive in a rapidly shifting market.

Tesla’s Market Share Shrinks in China

According to data from the China Passenger Car Association, Tesla’s share of the Chinese EV market has collapsed to 3.2% as of June 2025. This marks a dramatic fall from the 16% share it commanded in 2020.

The decline highlights the rise of domestic manufacturers who have been quick to adapt to local demand with affordable models, advanced technology, and flexible financing options.

Recent figures show Tesla slipping to fourth place in deliveries, with a 6.5% decline year-over-year. Meanwhile, competitors have surged, BYD deliveries rose nearly 20%, Geely’s deliveries jumped 283%, and XPeng achieved over 220% growth. Even new entrants like Xiaomi have gained traction, with its SU7 sedan racking up 240,000 orders and delivering 25,000 units in June alone.

Tesla Expands Lineup with Model Y Variant

Despite the pressures, Tesla is not backing away from its ambitions in China. Alongside the updated Model 3, the company is preparing to roll out a six-seat version of its popular Model Y SUV, also manufactured in Shanghai. Deliveries are expected to start this month, reflecting Tesla’s strategy to broaden its product range to appeal to a wider audience.

While Tesla insists its pricing adjustments are tied to production costs, analysts see the moves as a clear acknowledgment of China’s hyper-competitive EV landscape.

Incentives like insurance subsidies and interest-free loans suggest the company is willing to sacrifice margins to sustain relevance in a market that is increasingly dominated by homegrown automakers.

The post Tesla Cuts Model 3 Price in China Amid Intensifying EV Price War appeared first on CoinCentral.

Market Opportunity
Wink Logo
Wink Price(LIKE)
$0.00274
$0.00274$0.00274
+0.66%
USD
Wink (LIKE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23